Détail - canceropole-wordpress

From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials.

Tolboom N, Albert NL, Braat AJAT, Snijders TJ, Tabouret E, Taillandier L, Brendel M, Cecchin D, Aguiar-Fernandez P, Fraioli F, Guedj E, Traub-Weidinger T, Yakushev I, Van Weehaeghe D, Preusser M, Verger A

J Nucl Med. 2025 10 16;:

Mild cognitive dysfunction in hereditary spastic paraplegia 4 disease related to fluorodesoxyglucose cerebral positron emission tomography.

Miroglio R, Hocquel A, Ravel JM, Clément G, Puisieux S, Meyer M, Lavigne L, Dillier C, Liao L, Schmitt E, Hopes L, Michaud M, Pittion-Vouyovitch S, Lambert L, Guillaud-Bataille M, Banneau G, Bossenmeyer-Pourié C, Bonnet C, Verger A, Renaud M

Brain Commun. 2025 10 7;7(6):fcaf382

Experience of [Lu]Lu-PSMA-617-administration using totally implantable venous access port: simulated experiments and clinical SPECT analyses.

Lombard A, Journo S, Zaragori T, Olivier P, Claudin M, Marie PY, Bros M, Bordonné M, Verger A, Veran N, Citerne Q, Imbert L, Boursier C

EJNMMI Res. 2025 09 26;15(1):121

[Lu]Lu-DOTATATE for refractory meningiomas: factors associated with the therapeutic response and initial tumor dosimetric data.

Boursier C, Zaragori T, Garabedian N, Blonski M, Obara T, Taillandier L, Imbert L, Verger A

Eur J Nucl Med Mol Imaging. 2025 09 22;:

Prognostic Value of Comprehensive Analysis of Metastatic Prostate Tumor Changes from First to Last [Lu]Lu-PSMA Therapy Injections Through Serial High-Speed Whole-Body 360° Cadmium-Zinc-Telluride SPECT.

Kunsch J, Zaragori T, Olivier P, Claudin M, Marie PY, Raymond P, Heyer S, Verger A, Imbert L, Boursier C

J Nucl Med. 2025 09 11;:

Amyloid PET imaging in France: One-year experience and perspectives.

Verger A, Payoux P, Heyer S, Habert MO, Flaus A, Ribeiro M, De Leiris N, Pariente J, Wallon D, Ceccaldi M, Bombois S, Guedj E,

Rev Neurol (Paris). 2025 08 13;:

Parkinsonism and Charcot-Marie-Tooth neuropathy type 2P in a French patient with LRSAM1 pathogenic variation.

Ducatel P, Verger A, Selton M, Renaud M, Puisieux S, Grosset A, Hopes L, Michaud M

Eur J Med Genet. 2025 07 26;:105032

Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey.

Mair MJ, Lohmann P, Galldiks N, Belting M, Brandal P, Broen MPG, Cicone F, Daisne JF, Ducray F, Ehret F, Furtner J, Jakola AS, Niyazi M, Pellerino A, Rasschaert M, Razis E, Sahm F, Smits M, Tolboom N, Verger A, Le Rhun E, Minniti G, Weller M, Preusser M, Albert NL

Eur J Nucl Med Mol Imaging. 2025 06 4;:

RANO criteria for response assessment of brain metastases based on amino acid PET imaging.

Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, Koh ES, Law I, Le Rhun E, Mair MJ, Werner JM, Berghoff AS, Furtner J, Minniti G, Scott AM, Short SC, Ivanidze J, Johnson DR, Suchorska B, Tolboom N, Tonn JC, Verger A, Galanis E, Brastianos PK, Wen PY, Weller M, Lin NU, Preusser M

Nat Med. 2025 05 8;:

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): methodological application in [F]-FDOPA PET imaging.

Stien G, Zinsz A, Ahrari S, Taillandier L, Blonski M, Imbert L, Zaragori T, Verger A

EJNMMI Res. 2025 04 18;15(1):44

Reorganization of brain connectivity in post-COVID condition: a F-FDG PET study.

Verger A, Doyen M, Heyer S, Goehringer F, Bruyere A, Kaphan E, Chine M, Menard A, Horowitz T, Guedj E

EJNMMI Res. 2025 03 30;15(1):28

Brain F-FDG-PET abnormalities and their associations with neuropsychological assessment in initially hospitalized patients with post-COVID-19 conditions: a prospective and longitudinal study.

Heyer S, Meyer M, Hossu G, Doyen M, Bruyère A, Goehringer F, Tyvaert L, Hopes L, Verger A

Eur J Nucl Med Mol Imaging. 2025 03 26;:

Brain F-fluorodeoxyglucose positron emission tomography: An efficient tool at the initial diagnosis of nonlesional late onset epilepsy.

Puisieux S, Heyer S, Forthoffer N, Doyen M, Tyvaert L, Verger A

Epilepsia. 2025 02 26;:

Early Perfusion [123I]FP-CIT SPECT Imaging With a 360-degree CZT Camera in Dementia With Lewy Bodies.

Verger A, Imbert L, Cecchin D

Clin Nucl Med. 2025 02 26;:

Clinical impact of an explainable machine learning with amino acid PET imaging: application to the diagnosis of aggressive glioma.

Ahrari S, Zaragori T, Zinsz A, Hossu G, Oster J, Allard B, Al Mansour L, Bessac D, Boumedine S, Bund C, De Leiris N, Flaus A, Guedj E, Kas A, Keromnes N, Kiraz K, Kuijper FM, Maitre V, Querellou S, Stien G, Humbert O, Imbert L, Verger A

Eur J Nucl Med Mol Imaging. 2025 01 17;:

Lecanemab approval in EU: what should we be ready for?- the EANM perspective.

Yakushev I, Verger A, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Grimmer T, Tolboom N, Traub-Weidinger T, Guedj E, Van Weehaeghe D

Eur J Nucl Med Mol Imaging. 2025 01 10;:

Diagnostic Accuracy of Low-Dose Myocardial Perfusion Imaging in a Real-World Setting.

Perrin M, Claudin M, Djaballah K, Boursier C, Verger A, Imbert L, Roch V, Doyen M, Marie L, Karcher G, Popovic B, Lamiral Z, Camenzind E, Marie PY

J Nucl Cardiol. 2025 01 7;:102140

Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0.

Verger A, Tolboom N, Cicone F, Chang SM, Furtner J, Galldiks N, Gempt J, Guedj E, Huang RY, Johnson DR, Law I, Le Rhun E, Short SC, Bent MJVD, Weehaeghe DV, Vogelbaum MA, Wen PY, Albert NL, Preusser M

Eur J Nucl Med Mol Imaging. 2025 01 7;:

Metabolic Brain PET Connectivity.

Horowitz T, Doyen M, Caminiti SP, Yakushev I, Verger A, Guedj E

PET Clin. 2024 10 30;:

Brain PET Imaging in the Presurgical Evaluation of Drug-Resistant Focal Epilepsy.

Flaus A, Guedj E, Horowitz T, Semah F, Verger A, Hammers A

PET Clin. 2024 10 18;:

Early wave reflection of carotid artery is associated with 18F-FDG PET hypometabolism in Alzheimer's brain areas of cognitively normal adults.

Zimmermann G, Joly L, Schoepfer P, Doyen M, Roch V, Grignon R, Salvi P, Marie PY, Benetos A, Verger A

J Hypertens. 2024 10 2;:

Do we need dosimetry for optimization of theranostics in CNS tumors?

Cicone F, Gnesin S, Santo G, Stokke C, Bartolomei M, Cascini GL, Minniti G, Paganelli G, Verger A, Cremonesi M

Neuro Oncol. 2024 10 1;:

Emerging topics in neuroimaging.

Verger A, Morbelli S

Q J Nucl Med Mol Imaging. 2024 09;68(3):176-178

Translating the theranostic concept to neuro-oncology: disrupting barriers.

Albert NL, Le Rhun E, Minniti G, Mair MJ, Galldiks N, Tolboom N, Jakola AS, Niyazi M, Smits M, Verger A, Cicone F, Weller M, Preusser M,

Lancet Oncol. 2024 09;25(9):e441-e451

F-FDG PET can effectively rule out conversion to dementia and the presence of CSF biomarker of neurodegeneration: a real-world data analysis.

Heyer S, Simon M, Doyen M, Mortada A, Roch V, Jeanbert E, Thilly N, Malaplate C, Kearney-Schwartz A, Jonveaux T, Bannay A, Verger A

Alzheimers Res Ther. 2024 08 13;16(1):182

177Lu-labeled somatostatin receptor targeted radionuclide therapy dosimetry in meningioma: a systematic review.

Boursier C, Zaragori T, Imbert L, Verger A

Q J Nucl Med Mol Imaging. 2024 07 19;:

Metabolic brain connectivity reorganization in Alzheimer's disease patients: a systematic review.

Heyer S, Doyen M, Verger A

Q J Nucl Med Mol Imaging. 2024 07 17;:

Neuroimaging biomarkers in the biological definition of Parkinson's disease and dementia with Lewy bodies - EANM position on current state, unmet needs and future perspectives.

Brendel M, Guedj E, Yakushev I, Morbelli S, Höglinger GU, Tolboom N, Verger A, Albert NL, Cecchin D, Fernandez PA, Fraioli F, Traub-Weidinger T, Van Weehaeghe D, Barthel H

Eur J Nucl Med Mol Imaging. 2024 06 22;:

Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.

Albert NL, Preusser M, Traub-Weidinger T, Tolboom N, Law I, Palmer JD, Guedj E, Furtner J, Fraioli F, Huang RY, Johnson DR, Deroose CM, Herrmann K, Vogelbaum M, Chang S, Tonn JC, Weller M, Wen PY, van den Bent MJ, Verger A, Ivanidze J, Galldiks N

Eur J Nucl Med Mol Imaging. 2024 06 20;:

EANM perspectives for CZT SPECT in brain applications.

Verger A, Cecchin D, Guedj E, Albert NL, Brendel M, Fraioli F, Tolboom N, Traub-Weidinger T, Yakushev I, Van Weehaeghe D, Fernandez PA, Garibotto V, Imbert L

Eur J Nucl Med Mol Imaging. 2024 06 11;:

Amino-acid PET as a prognostic tool after post Stupp protocol temozolomide therapy in high-grade glioma patients.

Zinsz A, Ahrari S, Becker J, Mortada A, Roch V, Doriat L, Santi M, Blonski M, Taillandier L, Zaragori T, Verger A

J Neurooncol. 2024 06 6;:

EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours.

Van Weehaeghe D, Lapauw B, Fraioli F, Cecchin D, Verger A, Guedj E, Albert NL, Brendel M, Yakushev I, Barthel H, Traub-Weidinger T, Tolboom N, Giessen EV

Eur J Nucl Med Mol Imaging. 2024 04 30;:

The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions.

Zinsz A, Pouget C, Rech F, Taillandier L, Blonski M, Amlal S, Imbert L, Zaragori T, Verger A

Eur J Nucl Med Mol Imaging. 2024 04 19;:

Assessment of a one-week ketogenic diet on brain glycolytic metabolism and on the status epilepticus stage of a lithium-pilocarpine rat model.

Doyen M, Lambert C, Roeder E, Boutley H, Chen B, Pierson J, Verger A, Raffo E, Karcher G, Marie PY, Maskali F

Sci Rep. 2024 03 1;14(1):5063

EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.

Traub-Weidinger T, Arbizu J, Barthel H, Boellaard R, Borgwardt L, Brendel M, Cecchin D, Chassoux F, Fraioli F, Garibotto V, Guedj E, Hammers A, Law I, Morbelli S, Tolboom N, Van Weehaeghe D, Verger A, Van Paesschen W, von Oertzen TJ, Zucchetta P, Semah F

Eur J Nucl Med Mol Imaging. 2024 02 23;:

Application of PET imaging delta radiomics for predicting progression-free survival in rare high-grade glioma.

Ahrari S, Zaragori T, Zinsz A, Oster J, Imbert L, Verger A

Sci Rep. 2024 02 8;14(1):3256

Head-to-Head Comparison Between F-FDG PET and Leukocyte Scintigraphy to Monitor Treatment Responses in Necrotizing Otitis Externa.

Hurstel M, Vasseur A, Melki S, Veran N, Imbert L, Nguyen DT, Rumeau C, Verger A

J Otolaryngol Head Neck Surg. 2024 ;53:19160216241288810

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.

Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M

Lancet Oncol. 2024 01;25(1):e29-e41

Effects of medication on dopamine transporter imaging using [I]I-FP-CIT SPECT in routine practice.

Piatkova Y, Doyen M, Heyer S, Tahmazov A, Frismand S, Hopes L, Imbert L, Verger A

Eur J Nucl Med Mol Imaging. 2023 12 20;:

Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging.

Fraioli F, Albert N, Boellaard R, Galazzo IB, Brendel M, Buvat I, Castellaro M, Cecchin D, Fernandez PA, Guedj E, Hammers A, Kaplar Z, Morbelli S, Papp L, Shi K, Tolboom N, Traub-Weidinger T, Verger A, Van Weehaeghe D, Yakushev I, Barthel H

Eur J Nucl Med Mol Imaging. 2023 12 15;:

Ultra-fast whole-body bone tomoscintigraphies achieved with a high-sensitivity 360° CZT camera and a dedicated deep-learning noise reduction algorithm.

Bahloul A, Verger A, Lamash Y, Roth N, Dari D, Marie PY, Imbert L

Eur J Nucl Med Mol Imaging. 2023 12 12;:

Theranostics in Neurooncology: Heading Toward New Horizons.

Tolboom N, Verger A, Albert NL, Fraioli F, Guedj E, Traub-Weidinger T, Morbelli S, Herrmann K, Zucchetta P, Plasschaert SLA, Yakushev I, Weller M, Glas M, Preusser M, Cecchin D, Barthel H, Van Weehaeghe D

J Nucl Med. 2023 12 7;:

EANM position paper: theranostics in brain tumours-the present and the future.

Tolboom N, Verger A, Albert NL, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Herrmann K, Traub-Weidinger T, Morbelli S, Yakushev I, Zucchetta P, Barthel H, Van Weehaeghe D

Eur J Nucl Med Mol Imaging. 2023 09 12;:

Volume of the proximal half of the thoracic aorta is the most comprehensive FDG-PET/CT indicator of arterial aging throughout adulthood.

Hurstel M, Joly L, Imbert L, Zimmermann G, Roch V, Schoepfer P, Lamiral Z, Salvi P, Benetos A, Verger A, Marie PY

Eur J Hybrid Imaging. 2023 06 28;7(1):11

Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.

Boursier C, Zaragori T, Bros M, Bordonne M, Melki S, Taillandier L, Blonski M, Roch V, Marie PY, Karcher G, Imbert L, Verger A

Eur Radiol. 2023 05 6;:

Added value of [F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.

Darcourt J, Chardin D, Bourg V, Gal J, Schiappa R, Blonski M, Koulibaly PM, Almairac F, Mondot L, Le Jeune F, Collombier L, Kas A, Taillandier L, Verger A

Eur J Nucl Med Mol Imaging. 2023 04 22;:

Identification of resting-state networks using dynamic brain perfusion SPECT imaging: A fSPECT case report.

Doyen M, Hossu G, Heyer S, Zaragori T, Imbert L, Verger A

Front Hum Neurosci. 2023 04 20;17:1125765

Contribution of nuclear medicine to the diagnosis and management of primary brain tumours.

Horowitz T, Tabouret E, Graillon T, Salgues B, Chinot O, Verger A, Guedj E

Rev Neurol (Paris). 2023 03 16;:

FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective.

Verger A, Yakushev I, Albert NL, van Berckel B, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Morbelli S, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Barthel H

Eur J Nucl Med Mol Imaging. 2023 03 4;:

Targeted therapy monitoring of BRAF-V600-mutant Erdheim-Chester disease by fast quantitative whole-body bone CZT-tomoscintigraphies.

Melki S, Moulinet T, Verger A, Marie PY, Imbert L, Bahloul A

Eur J Hybrid Imaging. 2023 01 13;7(1):1

Implementing the Point Spread Function Deconvolution for Better Molecular Characterization of Newly Diagnosed Gliomas: A Dynamic F-FDOPA PET Radiomics Study.

Ahrari S, Zaragori T, Bros M, Oster J, Imbert L, Verger A

Cancers (Basel). 2022 11 23;14(23):

Differentiating high-grade glioma progression from treatment-related changes with dynamic [F]FDOPA PET: a multicentric study.

Rozenblum L, Zaragori T, Tran S, Morales-Martinez A, Taillandier L, Blonski M, Rech F, Galanaud D, Kas A, Verger A

Eur Radiol. 2022 11 11;:

Brain F-FDG PET imaging in outpatients with post-COVID-19 conditions: findings and associations with clinical characteristics.

Goehringer F, Bruyere A, Doyen M, Bevilacqua S, Charmillon A, Heyer S, Verger A

Eur J Nucl Med Mol Imaging. 2022 11 2;:

Metabolic connectivity is associated with seizure outcome in surgically treated temporal lobe epilepsies: A F-FDG PET seed correlation analysis.

Doyen M, Chawki MB, Heyer S, Guedj E, Roch V, Marie PY, Tyvaert L, Maillard L, Verger A

Neuroimage Clin. 2022 09 24;36:103210

2-[F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee.

Verger A, Barthel H, Tolboom N, Fraioli F, Cecchin D, Albert NL, van Berckel B, Boellaard R, Brendel M, Ekmekcioglu O, Semah F, Traub-Weidinger T, van de Weehaeghe D, Morbelli S, Guedj E

Eur J Nucl Med Mol Imaging. 2022 07 16;:

Reduced penetrance of an eastern French mutation in ATL1 autosomal-dominant inheritance (SPG3A): extended phenotypic spectrum coupled with brain F-FDG PET.

Hocquel A, Ravel JM, Lambert L, Bonnet C, Banneau G, Kol B, Tissier L, Hopes L, Meyer M, Dillier C, Michaud M, Lardin A, Kaminsky AL, Schmitt E, Liao L, Zhu F, Myriam B, Bossenmeyer-Pourié C, Verger A, Renaud M

Neurogenetics. 2022 07 5;:

Interactions Between Brain F-FDG PET Metabolism and Hemodynamic Parameters at Different Ages of Life: Results From a Prospective Cross-Sectional Study.

Zimmermann G, Joly L, Schoepfer P, Doyen M, Roch V, Grignon R, Salvi P, Marie PY, Benetos A, Verger A

Front Aging Neurosci. 2022 06 28;14:908063

Visual interpretation of brain hypometabolism related to neurological long COVID: a French multicentric experience.

Verger A, Kas A, Dudouet P, Goehringer F, Salmon-Ceron D, Guedj E

Eur J Nucl Med Mol Imaging. 2022 Mar 23;:

Multi-tracer and multiparametric PET imaging to detect the IDH mutation in glioma: a preclinical translational in vitro, in vivo, and ex vivo study.

Clément A, Zaragori T, Filosa R, Ovdiichuk O, Beaumont M, Collet C, Roeder E, Martin B, Maskali F, Barberi-Heyob M, Pouget C, Doyen M, Verger A

Cancer Imaging. 2022 Mar 18;22(1):16

PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area.

Verger A, Kas A, Darcourt J, Guedj E

Cancers (Basel). 2022 Feb 22;14(5):

Brain 18F-FDG PET in Cowden Syndrome.

Grangeret J, Frismand S, Muller M, Renaud M, Verger A

Clin Nucl Med. 2022 Feb 1;47(2):e118-e119

Multiparametric 18F-FDG and 68GA-DOTATOC PET Imaging in Bone Metastatic Meningioma Before Radionuclide Therapy: Assessment of Tumor Heterogeneity.

Mairal E, Chevalier E, Imbert L, Boursier-Joppin C, Verger A

Clin Nucl Med. 2022 Jan 15;:

Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma Patients.

Blonski M, Obara T, Brzenczek C, Pouget C, Dillier C, Meyer M, Lavigne L, Forthoffer N, Broussois A, Gauchotte G, Baron MH, Rech F, Mézières S, Gaudeau Y, Verger A, Vogin G, Anxionnat R, Moureaux JM, Taillandier L

Front Oncol. 2022 ;12:827897

Prospective Paired Comparison of 123I-FP-CIT SPECT Images Obtained With a 360°-CZT and a Conventional Camera.

Piatkova Y, Payoux P, Boursier C, Bordonne M, Roch V, Marie PY, Hossu G, Imbert L, Verger A

Clin Nucl Med. 2022 Jan 1;47(1):14-20

Relevance of Dynamic F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes.

Ahrari S, Zaragori T, Rozenblum L, Oster J, Imbert L, Kas A, Verger A

Biomedicines. 2021 Dec 16;9(12):

Effects of Carbidopa Premedication on F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis.

Bros M, Zaragori T, Rech F, Blonski M, Hossu G, Taillandier L, Marie PY, Verger A

Cancers (Basel). 2021 Oct 24;13(21):

Assessment of the routine reporting of very low-dose exercise-first myocardial perfusion SPECT from a large-scale real-world cohort and correlation with the subsequent reporting of coronary stenosis at angiography.

Chawki MB, Goncalves T, Boursier C, Bordonne M, Verger A, Imbert L, Perrin M, Claudin M, Roch V, Djaballah K, Popovic B, Camenzind E, Marie PY

Eur J Nucl Med Mol Imaging. 2021 Oct 16;:

Dynamic amino-acid PET in neuro-oncology: a prognostic tool becomes essential.

Verger A, Imbert L, Zaragori T

Eur J Nucl Med Mol Imaging. 2021 Sep 13;:

Early 18F-FDG PET Flare-up Phenomenon After CAR T-Cell Therapy in Lymphoma.

Boursier C, Perrin M, Bordonne M, Campidelli A, Verger A

Clin Nucl Med. 2021 Aug 16;:

SPECT/PET molecular imaging for parkinsonism: a fast-developing field.

Verger A, Grimaldi S, Ribeiro MJ, Frismand S, Guedj E

Ann Neurol. 2021 Aug 2;:

F-FDOPA PET for the non-invasive prediction of glioma molecular parameters: a radiomics study.

Zaragori T, Oster J, Roch V, Hossu G, Chawki MB, Grignon R, Pouget C, Gauchotte G, Rech F, Blonski M, Taillandier L, Imbert L, Verger A

J Nucl Med. 2021 May 20;:

The pons as reference region for intensity normalization in semi-quantitative analysis of brain FDG PET: application to metabolic changes related to ageing in conventional and digital control databases.

Verger A, Doyen M, Campion JY, Guedj E

EJNMMI Res. 2021 Mar 24;11(1):31

Brain F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis.

Bordonne M, Chawki MB, Doyen M, Kas A, Guedj E, Tyvaert L, Verger A

Eur J Nucl Med Mol Imaging. 2021 Mar 7;:

Prognostic Impact of 18-F-Florbetaben Amyloid PET Imaging in Patients with Isolated Increases in Cerebrospinal Fluid Phospho-Tau Biomarkers: A Longitudinal Study.

Jardel A, Hopes L, Malaplate C, Roch V, Manca C, Rivasseau Jonveaux T, Verger A

J Alzheimers Dis. 2021 Mar 4;:

Recurrent seizures of autoimmune origin: emerging phenotypes.

Goudot M, Frismand S, Hopes L, Verger A, Joubert B, Honnorat J, Tyvaert L

J Neurol. 2021 Feb 27;:

In vivo characterization of physiological and metabolic changes related to isocitrate dehydrogenase 1 mutation expcression by multiparametric MRI and MRS in a rat model with orthotopically grafted human-derived glioblastoma cell lines.

Clément A, Doyen M, Fauvelle F, Hossu G, Chen B, Barberi-Heyob M, Hirtz A, Stupar V, Lamiral Z, Pouget C, Gauchotte G, Karcher G, Beaumont M, Verger A, Lemasson B

NMR Biomed. 2021 Feb 17;:e4490

Signs of tracheobronchitis may constitute the principal finding on the lung SPECT/CT images of COVID-19 patients.

Bahloul A, Verger A, Mandry D, Jeulin H, Goehringer F, Karcher G, Imbert L, Marie PY

Eur J Nucl Med Mol Imaging. 2021 Jan 8;:

Dynamic F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?

Zaragori T, Doyen M, Rech F, Blonski M, Taillandier L, Imbert L, Verger A

Front Oncol. 2021 ;11:735257

Effect of Point Spread Function Deconvolution in Reconstruction of Brain F-FDG PET Images on the Diagnostic Thinking Efficacy in Alzheimer's Disease.

Doyen M, Mairal E, Bordonne M, Zaragori T, Roch V, Imbert L, Verger A

Front Med (Lausanne). 2021 ;8:721551

Clinical impact of digital and conventional PET control databases for semi-quantitative analysis of brain F-FDG digital PET scans.

Mairal E, Doyen M, Rivasseau-Jonveaux T, Malaplate C, Guedj E, Verger A

EJNMMI Res. 2020 Nov 30;10(1):144

High-quality brain perfusion SPECT images may be achieved with a high-speed recording using 360° CZT camera.

Bordonne M, Chawki MB, Marie PY, Zaragori T, Roch V, Grignon R, Imbert L, Verger A

EJNMMI Phys. 2020 Nov 4;7(1):65

CT abnormalities evocative of lung infection are associated with lower F-FDG uptake in confirmed COVID-19 patients.

Bahloul A, Boursier C, Jeulin H, Imbert L, Mandry D, Karcher G, Marie PY, Verger A

Eur. J. Nucl. Med. Mol. Imaging. 2020 Aug 18;:

Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET Experience.

Zaragori T, Castello A, Guedj E, Girard A, Galldiks N, Albert NL, Lopci E, Verger A

Clin Nucl Med. 2020 Aug 15;:

Involvement of the cerebellum in EMDR efficiency: a metabolic connectivity PET study in PTSD.

Verger A, Rousseau PF, Malbos E, Chawki MB, Nicolas F, Lançon C, Khalfa S, Guedj E

Eur J Psychotraumatol. 2020 Jun 29;11(1):1767986

Use of static and dynamic [F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progression.

Zaragori T, Ginet M, Marie PY, Roch V, Grignon R, Gauchotte G, Rech F, Blonski M, Lamiral Z, Taillandier L, Imbert L, Verger A

EJNMMI Res. 2020 May 29;10(1):56

Tracheobronchitis signs observed on ventilation lung scintigraphy during the course of COVID-19 infection.

Verger A, Bahloul A, Melki S, Karcher G, Imbert L, Marie PY

Eur. J. Nucl. Med. Mol. Imaging. 2020 May 6;:

PET imaging of COVID-19: the target and the number.

Guedj E, Verger A, Cammilleri S

Eur. J. Nucl. Med. Mol. Imaging. 2020 Apr 17;:

Head-to-head comparison between digital and analog PET of human and phantom images when optimized for maximizing the signal-to-noise ratio from small lesions.

Salvadori J, Odille F, Verger A, Olivier P, Karcher G, Marie PY, Imbert L

EJNMMI Phys. 2020 Feb 21;7(1):11

Is IDH mutation status associated with F-FDopa PET uptake?

Zaragori T, Guedj E, Verger A

Ann Nucl Med. 2020 Jan 30;:

Adult Diffuse Low-Grade Gliomas: 35-Year Experience at the Nancy France Neurooncology Unit.

Obara T, Blonski M, Brzenczek C, Mézières S, Gaudeau Y, Pouget C, Gauchotte G, Verger A, Vogin G, Moureaux JM, Duffau H, Rech F, Taillandier L

Front Oncol. 2020 ;10:574679

Brain perfusion SPECT acquired using a dedicated brain configuration on a 360° whole-body CZT-camera.

Bordonne M, Marie PY, Imbert L, Verger A

J Neuroradiol. 2019 Nov 28;:

From metabolic connectivity to molecular connectivity: application to dopaminergic pathways.

Verger A, Horowitz T, Chawki MB, Eusebio A, Bordonne M, Azulay JP, Girard N, Guedj E

Eur. J. Nucl. Med. Mol. Imaging. 2019 Nov 18;:

GAD65-Ab encephalitis and subtle focal status epilepticus.

Goudot M, Frismand S, Hopes L, Verger A, Joubert B, Honnorat J, Tyvaert L

Epileptic Disord. 2019 Oct 19;:

Augmented planar bone scintigraphy obtained from a whole-body SPECT recording of less than 20 min with a high-sensitivity 360° CZT camera.

Melki S, Chawki MB, Marie PY, Imbert L, Verger A

Eur. J. Nucl. Med. Mol. Imaging. 2019 Oct 12;:

Integration of dynamic parameters in the analysis of F-FDopa PET imaging improves the prediction of molecular features of gliomas.

Ginet M, Zaragori T, Marie PY, Roch V, Gauchotte G, Rech F, Blonski M, Lamiral Z, Taillandier L, Imbert L, Verger A

Eur. J. Nucl. Med. Mol. Imaging. 2019 Sep 16;:

Head-to-head comparison of image quality between brain F-FDG images recorded with a fully digital versus a last-generation analog PET camera.

Salvadori J, Imbert L, Perrin M, Karcher G, Lamiral Z, Marie PY, Verger A

EJNMMI Res. 2019 Jul 12;9(1):61

Increase of precuneus metabolism correlates with reduction of PTSD symptoms after EMDR therapy in military veterans: an 18F-FDG PET study during virtual reality exposure to war.

Rousseau PF, Malbos E, Verger A, Nicolas F, Lançon C, Khalfa S, Guedj E

Eur. J. Nucl. Med. Mol. Imaging. 2019 May 31;:

Amyloid PETs are commonly negative in suspected Alzheimer's disease with an increase in CSF phosphorylated-tau protein concentration but an Aβ42 concentration in the very high range: a prospective study.

Manca C, Rivasseau Jonveaux T, Roch V, Marie PY, Karcher G, Lamiral Z, Malaplate C, Verger A

J. Neurol.. 2019 Apr 8;:

Assessment of 18F-Florbetaben Amyloid PET Imaging in Patients with Suspected Alzheimer's Disease and Isolated Increase in Cerebrospinal Fluid Tau Proteins.

Manca C, Hopes L, Kearney-Schwartz A, Roch V, Karcher G, Baumann C, Marie PY, Malaplate-Armand C, Rivasseau Jonveaux T, Verger A

J. Alzheimers Dis.. 2019 Mar 11;:

Left ventricular ejection fraction determined with the simulation of a very low-dose CZT-SPECT protocol and an additional count-calibration on planar radionuclide angiographic data.

Tissot H, Roch V, Morel O, Veran N, Perrin M, Claudin M, Verger A, Karcher G, Marie PY, Imbert L

J Nucl Cardiol. 2019 Feb 27;:

High-Resolution Brain 18F-FDG Images Provided by Fully Digital PET.

Salvadori J, Perrin M, Marie PY, Imbert L, Verger A

Clin Nucl Med. 2019 Feb 15;:

Assessment of myocardial CZT-SPECT recording in a forward-leaning "biker-like" position.

Perrin M, Roch V, Claudin M, Verger A, Boutley H, Karcher G, Baumann C, Veran N, Marie PY, Imbert L

J. Nucl. Med.. 2018 Nov 2;:

Brain metabolism and related connectivity in patients with acrophobia treated by virtual reality therapy: an F-FDG PET pilot study sensitized by virtual exposure.

Verger A, Malbos E, Reynaud E, Mallet P, Mestre D, Pergandi JM, Khalfa S, Guedj E

EJNMMI Res. 2018 Oct 1;8(1):93

The renaissance of functional F-FDG PET brain activation imaging.

Verger A, Guedj E

Eur. J. Nucl. Med. Mol. Imaging. 2018 Sep 29;:

Role of amino-acid PET in high-grade gliomas: limitations and perspectives.

Verger A, Arbizu J, Law I

Q J Nucl Med Mol Imaging. 2018 Sep;62(3):254-266

Brain PET substrate of impulse control disorders in Parkinson's disease: A metabolic connectivity study.

Verger A, Klesse E, Chawki MB, Witjas T, Azulay JP, Eusebio A, Guedj E

Hum Brain Mapp. 2018 Aug;39(8):3178-3186

Metabolic Positron Emission Tomography Response to Gamma Knife of the Ventral Intermediate Nucleus in Essential Tremor.

Verger A, Witjas T, Carron R, Eusebio A, Boutin E, Azulay JP, Regis J, Guedj E

Neurosurgery. 2018 Jul 30;:

Comparison of O-(2-F-Fluoroethyl)-L-Tyrosine Positron Emission Tomography and Perfusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Patients with Progressive and Recurrent Glioma: A Hybrid Positron Emission Tomography/Magnetic Resonance Study.

Verger A, Filss CP, Lohmann P, Stoffels G, Sabel M, Wittsack HJ, Kops ER, Galldiks N, Fink GR, Shah NJ, Langen KJ

World Neurosurg. 2018 May;113:e727-e737

Investigation of cis-4-[F]Fluoro-D-Proline Uptake in Human Brain Tumors After Multimodal Treatment.

Verger A, Stoffels G, Galldiks N, Lohmann P, Willuweit A, Neumaier B, Geisler S, Langen KJ

Mol Imaging Biol. 2018 Apr 23;:

A high F-FDOPA uptake is associated with a slow growth rate in diffuse Grade II-III gliomas.

Isal S, Gauchotte G, Rech F, Blonski M, Planel S, Chawki MB, Karcher G, Marie PY, Taillandier L, Verger A

Br J Radiol. 2018 Apr;91(1084):20170803

Added value of F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study.

Ceccaldi M, Jonveaux T, Verger A, Krolak-Salmon P, Houzard C, Godefroy O, Shields T, Perrotin A, Gismondi R, Bullich S, Jovalekic A, Raffa N, Pasquier F, Semah F, Dubois B, Habert MO, Wallon D, Chastan M, Payoux P, ,Stephens A, Guedj E

Alzheimers Dement. 2018 Mar;14(3):293-305

Static and dynamic F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.

Verger A, Stoffels G, Bauer EK, Lohmann P, Blau T, Fink GR, Neumaier B, Shah NJ, Langen KJ, Galldiks N

Eur. J. Nucl. Med. Mol. Imaging. 2018 03;45(3):443-451

Cross-sectional variations of white and grey matter in older hypertensive patients with subjective memory complaints.

Chetouani A, Chawki MB, Hossu G, Kearney-Schwartz A, Chauveau-Beuret F, Bracard S, Roch V, Lebon V, Marie PY, Benetos A, Joly L, Verger A

Neuroimage Clin. 2018 ;17:804-810

Evaluation of factors influencing F-FET uptake in the brain.

Verger A, Stegmayr C, Galldiks N, Van Der Gucht A, Lohmann P, Stoffels G, Shah NJ, Fink GR, Eickhoff SB, Guedj E, Langen KJ

Neuroimage Clin. 2018 ;17:491-497

Voxel-based 18F-FET PET segmentation and automatic clustering of tumor voxels: A significant association with IDH1 mutation status and survival in patients with gliomas.

Blanc-Durand P, Van Der Gucht A, Verger A, Langen KJ, Dunet V, Bloch J, Brouland JP, Nicod-Lalonde M, Schaefer N, Prior JO

PLoS ONE. 2018 ;13(6):e0199379

Comparison of F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study.

Verger A, Filss CP, Lohmann P, Stoffels G, Sabel M, Wittsack HJ, Kops ER, Galldiks N, Fink GR, Shah NJ, Langen KJ

Eur. J. Nucl. Med. Mol. Imaging. 2017 Dec;44(13):2257-2265

Changes of metabolism and functional connectivity in late-onset deafness: Evidence from cerebral F-FDG-PET.

Verger A, Roman S, Chaudat RM, Felician O, Ceccaldi M, Didic M, Guedj E

Hear. Res.. 2017 09;353:8-16

Predictive value of brain 18F-FDG PET/CT in macrophagic myofasciitis?: A case report.

Van Der Gucht A, Abulizi M, Blanc-Durand P, Aoun-Sebaiti M, Emsen B, Gherardi RK, Verger A, Authier FJ, Itti E

Medicine (Baltimore). 2017 Sep;96(39):e8134

IDH mutation is paradoxically associated with higher F-FDOPA PET uptake in diffuse grade II and grade III gliomas.

Verger A, Metellus P, Sala Q, Colin C, Bialecki E, Taieb D, Chinot O, Figarella-Branger D, Guedj E

Eur. J. Nucl. Med. Mol. Imaging. 2017 Aug;44(8):1306-1311

Is the information provided by amino acid PET radiopharmaceuticals clinically equivalent in gliomas?

Verger A, Taieb D, Guedj E

Eur. J. Nucl. Med. Mol. Imaging. 2017 08;44(8):1408-1410

Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study.

Richieri R, Jouvenoz D, Verger A, Fiat P, Boyer L, Lançon C, Guedj E

Eur. J. Nucl. Med. Mol. Imaging. 2017 Jun;44(6):1051-1055

FDG Brain PET/CT Revealing Bilateral Thalamostriatal Activation During a Symptomatic Episode in a Patient With Kleine-Levin Syndrome.

Drouet C, Morel O, Verger A, Guedj E, Boulahdour H

Clin Nucl Med. 2017 May;42(5):e261-e262

Low-dose dual-isotope procedure planed for myocardial perfusion CZT-SPECT and assessed through a head-to-head comparison with a conventional single-isotope protocol.

Imbert L, Roch V, Merlin C, Djaballah W, Cachin F, Perrin M, Claudin M, Verger A, Boutley H, Karcher G, Marie PY

J Nucl Cardiol. 2017 May;:

Memory Alterations and White Matter Hyperintensities in Elderly Patients With Hypertension: The ADELAHYDE-2 Study.

Ferreira JP, Kearney Schwartz A, Watfa G, Zohra L, Felblinger J, Boivin JM, Bracard S, Hossu G, Verger A, Joly L, Zannad F, Rossignol P, Benetos A

J Am Med Dir Assoc. 2017 May 1;18(5):451.e13-451.e25

Usefulness of 18F-FDG PET Associated With a High-Fat, Low-Carbohydrate Preparation for the Detection of a Myocardial-Embedded Metastasis.

Djaileb L, Mandry D, Riou L, Marie PY, Verger A

Clin Nucl Med. 2017 May;42(5):e249-e250

Brain F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis.

Van Der Gucht A, Aoun Sebaiti M, Guedj E, Aouizerate J, Yara S, Gherardi RK, Evangelista E, Chalaye J, Cottereau AS, Verger A, Bachoud-Levi AC, Abulizi M, Itti E, Authier FJ

J. Nucl. Med.. 2017 Mar;58(3):492-498

Predictive medicine: towards a multi-parametric imaging for a personal risk stratification.

Guedj E, Cammilleri S, Verger A

Eur. J. Nucl. Med. Mol. Imaging. 2017 Feb;44(2):196-198

Cerebral 18F-FDG PET in macrophagic myofasciitis: An individual SVM-based approach.

Blanc-Durand P, Van Der Gucht A, Guedj E, Abulizi M, Aoun-Sebaiti M, Lerman L, Verger A, Authier FJ, Itti E

PLoS ONE. 2017 ;12(7):e0181152

Quantitative SPM Analysis Involving an Adaptive Template May Be Easily Applied to [(18)F]FDG PET Images of the Rat Brain.

Poussier S, Maskali F, Vexiau G, Verger A, Boutley H, Karcher G, Raffo E, Marie PY

Mol Imaging Biol. 2017 Jan;:

123I-FP-CIT-SPECT in Encephalitis Involving Substantia Nigra.

Tissot H, Frismand S, Marie PY, Gospodaru N, Verger A

Clin Nucl Med. 2016 Oct;41(10):e445-6

Routine evaluation of left ventricular function using CZT-SPECT, with low injected activities and limited recording times.

Claudin M, Imbert L, Djaballah W, Veran N, Poussier S, Roch V, Perrin M, Verger A, Boutley H, Karcher G, Marie PY

J Nucl Cardiol. 2016 Sep;:

Temporal epilepsy lesions may be detected by the voxel-based quantitative analysis of brain FDG-PET images using an original block-matching normalization software.

Verger A, Yagdigul Y, Van Der Gucht A, Poussier S, Guedj E, Maillard L, Malandain G, Hossu G, Fay R, Karcher G, Marie PY

Ann Nucl Med. 2016 May;30(4):272-8

FDG PET/CT in Type I Glycogen Storage Disease.

Manca C, Claudin M, Belle A, Marie PY, Verger A

Clin Nucl Med. 2016 Apr;41(4):e200-1

FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis.

Van Der Gucht A, Aoun-Sebaiti M, Kauv P, Guedj E, Aouizerate J, Verger A, Gherardi RK, Bachoud-Levi AC, Authier FJ, Itti E

Nucl Med Mol Imaging. 2016 Mar;50(1):80-4

Influence of Thoracic Aortic Inflammation and Calcifications on Arterial Stiffness and Cardiac Function in Older Subjects.

Joly L, Mandry D, Verger A, Labat C, Watfa G, Roux V, Karcher G, Marie PY, Benetos A

J Nutr Health Aging. 2016 Mar;20(3):347-54

Grey-Matter Metabolism in Relation with White-Matter Lesions in Older Hypertensive Patients with Subjective Memory Complaints: A Pilot Voxel-Based Analysis Study.

Verger A, Hossu G, Kearney-Schwartz A, Bracard S, Roch V, Van der Gucht A, Fay R, Benetos A, Marie PY, Joly L

Cerebrovasc. Dis.. 2016 ;42(1-2):106-9

Central pulse pressure is a determinant of heart and brain remodeling in the elderly: a quantitative MRI and PET pilot study.

Verger A, van der Gucht A, Guedj E, Marie PY, Hossu G, Mandry D, Morel O, Perrin M, Fay R, Benetos A, Joly L

J. Hypertens.. 2015 Jul;33(7):1378-85

Stress-first protocol for myocardial perfusion SPECT imaging with semiconductor cameras: high diagnostic performances with significant reduction in patient radiation doses.

Perrin M, Djaballah W, Moulin F, Claudin M, Veran N, Imbert L, Poussier S, Morel O, Besseau C, Verger A, Boutley H, Karcher G, Marie PY

Eur. J. Nucl. Med. Mol. Imaging. 2015 Jun;42(7):1004-11

Pr VERGER Antoine

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Projets

Publications